Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease.

Immunother Adv · 2026 · PMC13049483 · PMID 41937917

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

There was a slight trend of lower exposure for the 2 to <6 years age group compared with other age groups; however, this was likely driven by the data from one patient in this age group with low exposure.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.